Home/TAmiRNA/Matthias Hackl
MH

Matthias Hackl

CEO / CSO

TAmiRNA

TAmiRNA Pipeline

DrugIndicationPhase
hepatomiR®Liver Disease (e.g., NAFLD, fibrosis)IVD Kit
osteomiR®Osteoporosis / Bone MetabolismRUO Kit
thrombomiR®Cardiovascular Disease / Platelet FunctionRUO Kit
toxomiR®Drug-Induced ToxicityRUO Kit
senomiR®Cellular Senescence / Age-related DiseasesResearch